- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01885416
Impact of Dairy Products on Postprandial Inflammation
November 18, 2013 updated by: Guy Vergeres, Agroscope Liebefeld-Posieux Research Station ALP
The Impact of Dairy Products on Postprandial Inflammation in Obese Males
The study will quantitatively evaluate the systemic, postprandial inflammatory and metabolic response to the ingestion of three different meals in obese subjects.
The administered meals will differ in the proportion of dairy products.
Postprandial response will be monitored during 6 hours after meal consumption.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bern, Switzerland, 3010
- University Hospital, Inselspital Berne
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- male
- BMI ≥ 20 kg/m2
- age 25-55 y
- informed consent
Exclusion Criteria:
- Physiological or psychological diseases
- Allergies to food or intolerance to high-fat meal
- Vegetarians
- Chronic intake of drugs
- Smokers
- Diabetes mellitus Type I and II
- Debilitating kidney diseases
- Debilitating liver diseases
- Clinically established coronary heart diseases
- Ingestion of vitamins or dietary supplements during the course of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: high fat meal without dairy products
|
|
Experimental: high fat meal with additional milk
|
|
Experimental: dairy product meal
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Inflammation markers in blood plasma (IL-6, TNF-alpha)
Time Frame: 0,6h
|
0,6h
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Biomarkers in blood (serum insulin, plasma glucose, GLP-1, lipids)
Time Frame: 0,1,2,4,6h
|
0,1,2,4,6h
|
Endotoxin in blood serum
Time Frame: 0,6h
|
0,6h
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Blood cell transcriptome
Time Frame: 0,2,4,6h
|
0,2,4,6h
|
blood serum metabolome
Time Frame: 0,2,4,6h
|
0,2,4,6h
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Kur Laederach, MD, University Hospital Inselspital, Berne
- Study Director: Alexandra Schmid, Agroscope Liebefeld-Posieux ALP
- Study Director: Caroline Buri, MD, PhD, University Hospital Inselspital, Berne
- Study Director: Guy Vergères, PhD, Agroscope Liebefeld-Posieux ALP
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2013
Primary Completion (Actual)
September 1, 2013
Study Completion (Actual)
November 1, 2013
Study Registration Dates
First Submitted
June 19, 2013
First Submitted That Met QC Criteria
June 20, 2013
First Posted (Estimate)
June 25, 2013
Study Record Updates
Last Update Posted (Estimate)
November 19, 2013
Last Update Submitted That Met QC Criteria
November 18, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NUTRICHIP-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammation
-
University of EdinburghUmeå UniversityCompletedSystemic Inflammation | Respiratory InflammationSweden
-
University of AarhusAarhus University Hospital; University of CopenhagenCompletedSystemic Inflammation | Airway InflammationDenmark
-
Sykehuset TelemarkRikshospitalet University Hospital; Helse Sor-OstCompletedAirway Inflammation | Peripheral Blood Inflammation Markers | Cement Dust ExposureNorway
-
Assistance Publique - Hôpitaux de ParisCompletedDigestive InflammationFrance
-
Pamukkale UniversityCompletedPeriodontal InflammationTurkey
-
Universidade Federal do ParaCompleted
-
KLE Society's Institute of Dental SciencesCompletedRegenerative InflammationIndia
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Oral Science International Inc.AdvarraNot yet recruiting
Clinical Trials on consumption of high fat test meal without dairy products
-
Laval UniversityCompleted
-
Kirsten BellMcMaster UniversityRecruiting
-
University of CopenhagenCompleted
-
Agroscope Liebefeld-Posieux Research Station ALPCompletedObesity | Nutritional InterventionSwitzerland
-
University of AarhusDanish Diabetes AcademyCompletedType 2 Diabetes | NAFLDDenmark
-
Insel Gruppe AG, University Hospital BernRecruitingMicrobial Colonization | Diet, HealthySwitzerland
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingObesity | type1diabetesUnited States
-
Universidade do PortoCompletedMeal-Exercise Challenge and Physical Activity Reduction Impact on Immunity and Inflammation (MERIIT)Obesity | AsthmaPortugal
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsCanada
-
University of MinnesotaCompleted